Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipoprotein lipids

Current Opinion in Lipidology

Volumn 15, Issue 3, 2004, Pages 287-295

  Connelly, Margery A ^a   Williams, David L ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD36; Cholesteryl ester; Endothelial nitric oxide synthase; Free cholesterol; High density lipoprotein; Low density lipoprotein; Nitric oxide; Reverse cholesterol transport; Scavenger receptor class B type I; Selective uptake

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL ESTER; FATTY ACID; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN; RECEPTOR SUBUNIT; SCAVENGER RECEPTOR;

BLOOD VESSEL PERMEABILITY; BLOOD VESSEL WALL; CHOLESTEROL TRANSPORT; FATTY ACID TRANSPORT; HEALTH SURVEY; HEART PROTECTION; HUMAN; LIGAND BINDING; LIVER; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD36; ARTERIOSCLEROSIS; BIOLOGICAL TRANSPORT; CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER;

EID: 2642521483     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200406000-00008     Document Type: Review

References (113)

1. Calvo D, Vega MA. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 1993; 268:18929-18935.
2. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related Class B Scavenger Receptor. J Biol Chem 1994; 269:21003-21009.
3. Vinals M, Xu S, Vasile E, Krieger M. Identification of the N-Linked I(HDL) receptor SR-BI and assessment of their effects on HDL binding and selective lipid uptake. J Biol Chem 2003; 278:5325-5332.
4. Abumrad NA, Sfeir Z, Connelly MA, Coburn C. Lipid transporters: membrane transport systems for cholesterol and fatty acids. Curr Opin Clin Nutr Metab Care 2000; 3:255-262.
5. Ibrahimi A, Abumrad NA. Role of CD36 in membrane transport of long-chain fatty acids. Curr Opin Clin Nutr Metab Care 2002; 5:139-145.
6. Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520.
7. Krieger M. Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 1999; 68:523-558.
8. Williams DL, Connelly MA, Temel RE, et al. Scavenger receptor BI (SR-BI) and cholesterol trafficking. Curr Opin Lipidology 1999; 10:329-339.
9. Williams DL, Temel RE, Connelly MA. Roles of scavenger receptor BI and APO A-I in selective uptake of HDL cholesterol by adrenal cells. Endocr Res 2000; 26:639-651.
10. Silver DL, Tall AR. The cellular biology of scavenger receptor class B type I. Curr Opin Lipidology 2001; 12:497-504.
11. Azhar SR. Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation of steroidogenesis. Mol Cell Endocrinol 2002; 195:1-26.
12. Rigotti A, Miettinen HE, Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 2003; 24:357-387. This is a very comprehensive review of SR-BI literature with an emphasis on the physiological as well as the pathophysiological roles of SR-BI.
13. Connelly MA, Williams DL. SR-BI and cholesterol uptake into steroidogenic cells. Trends Endocrinol Metab 2003; 14:467-472. This review emphasizes the current knowledge of SR-BI function in the adrenal gland.
14. Trigatti BLK. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler Thromb 2003; 23:1732-1738. This review emphasizes SR-BI's role as a physiologically relevant receptor and its protective effect on atherogenesis.
15. Azhar S, Leers-Sucheta S, Reaven E. Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and 'selective' pathway connection. Front Biosci 2003; 8:998-1029. This is a very comprehensive review of SR-BI literature that provides details about SR-BI function in all of the steroidogenic tissues.
16. Rhainds DB. The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders. Int J Biochem Cell Biol 2004; 36:39-77.
17. Glass C, Pittman RC, Weinstein DB, Steinberg D. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: Selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad. Sci U S A 1983; 80:5435-5439.
18. Reaven E, Chen Y-DI, Spicher M, Azhar S. Morphological evidence that high density lipoproteins are not internalized by steroid-producing cells during in situ organ perfusion. J Clin Invest 1984; 74:1384-1397.
19. Glass C, Pittman RC, Civen M, Steinberg D. Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J Biol Chem 1985; 260:744-750.
20. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232:34-47.
21. Gu X, Trigatti B, Xu S, et al. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 1998; 273:26338-26348.
22. Connelly MA, Klein SM, Azhar S, et al. Comparison of class B scavenger receptors, CD36 and SR-BI, shows that both receptors mediate HDL-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J Biol Chem 1999; 274:41-47.
23. Liu T, Krieger M, Kan HY, Zannis VI. The effects of mutations in helices 4 and 6 of apoA-I on SR-BI-mediated cholesterol efflux suggest that formation of a productive complex between reconstituted HDL and SR-BI is required for efficient lipid transport. J Biol Chem 2002; 277:21578-21584.
24. Temel RE, Walzem RL, Banka CL, Williams DL. Apolipoprotein A-I is necessary for the in vivo formation of HDL competent for scavenger receptor BI-mediated cholesteryl ester selective uptake. J Biol Chem 2002; 277:26565-26572.
25. -I- HDL by apoA-I requires HDL reorganization by LCAT. J Biol Chem 2003; 278:4792-4799.
26. Thuahnai ST, Lund-Katz S, Dhanasekaran P, et al. SR-BI-mediated cholesteryl ester selective uptake and efflux of unesterified cholesterol: Influence of HDL size and structure. J Biol Chem 2004; 279:12448-12455.
27. Nieland TJ, Penman M, Dori L, et al. Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc Natl Acad Sci U S A 2002; 99:15422-15427.
28. Williams DL, de la Llera-Moya M, Thuahnai ST, et al. Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic α-helix as a recognition motif. J Biol Chem 2000; 275:18897-18904.
29. Reaven E, Cortez Y, Leers-Sucheta S, et al. Dimerization of the scavenger receptor class B type I (SR-BI): formation, function and localization in diverse cells and tissues. J Lipid Res 2004; 45:513-528.
30. Shi X-Y, Azhar S, Reaven E. Reconstitution of the lipoprotein cholesteryl ester transfer process using isolated rat ovary plasma membranes. Biochemistry 1992; 31:3230-3236.
31. Connelly MA, Kellner-Weiber G, Rothblat GH, Williams DL. Scavenger receptor, class B, type I (SR-BI)-directed HDL-cholesteryl ester hydrolysis. J Lipid Res 2003; 44:331-341.
32. Liu B, Krieger M. Highly purified scavenger receptor class B, type I reconstituted into phosphatidylcholine/cholesterol liposomes mediates high affinity high density lipoprotein binding and selective lipid uptake. J Biol Chem 2002; 277:34125-34135.
33. Rodrigueza WV, Thuahnai ST, Temel RE, et al. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J Biol Chem 1999; 274:20344-20350.
34. Silver DL, Wang N, Tall AR. Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J Clin Invest 2000; 105:151-159.
35. Webb NR, de Villiers WJ, Connell PM, et al. Alternative forms of the scavenger receptor BI (SR-BI). J Lipid Res 1997; 38:1490-1495.
36. Eckhardt ER, Cai L, un B, Webb NR, van der Westhuyzen DR. HDL uptake by scavenger receptor BII. J Biol Chem 2004; 279:14372-14381.
37. Peng Y, Akmentin W, Connelly MA, et al. Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein. Mol Biol Cell 2004; 15:384-396. This thorough study took a careful look at the localization of SR-BI in different cell types. It conclusively showed that SR-BI in not localized in significant amounts in caveolae as previously thought and offers a new view of the microdomains within the plasma membrane that SR-BI is found.
38. Ikemoto M, Arai H, Feng D, et al. Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc Natl Acad Sci U S A 2000; 97:6538-6543.
39. Silver DL. A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver. J Biol Chem 2002; 277:34042-34047.
40. Kocher O, Yesilaltay A, Cirovic C, et al. Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J Biol Chem 2003; 278:52820-52825. This paper elegantly shows the liver-specific regulation of SR-BI by PDZK1 and how SR-BI deregulation in the liver affects lipoprotein metabolism
41. Silver DL, Wang N, Vogel S. Identification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levels. J Biol Chem 2003; 278:28528-28532. This report furthers the research described in the previous reference by showing another player, SPAP, that regulates SR-BI cell surface expression in the liver through regulation of PDZK1.
42. Chinetti G, Gbaguidi FG, Griglio S, et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 2000; 101:2411-2417.
43. Mardones P, Pilon A, Bouly M, et al. Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J Biol Chem 2003; 278:7884-7890. This is an interesting paper that shows that fibrate treatment of mice down-regulates expression of SR-BI in the liver even though it up regulates SR-BI in macrophages.
44. Fu T, Kozarsky KF, Borensztajn J. Overexpression of SR-BI by adenoviral vector reverses the fibrate induced hypercholesterolemia of apolipoprotein E-deficient mice. J Biol Chem 2003; 278:52559-52563.
45. Babitt J, Trigatti B, Rigotti A, et al. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-Glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 1997; 272:13242-13249.
46. Graf GA, Connell PM, van der Westhuyzen DR, Smart EJ. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesteryl ethers into caveolae. J Biol Chem 1999; 274:12043-12048.
47. Matveev S, van der Westhuyzen DR, Smart EJ. Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J Lipid Res 1999; 40:1647-1654.
48. Matveev S, Uittenbogaard A, van Der W, Smart EJ. Caveolin-1 negatively regulates SR-BI mediated selective uptake of high-density lipoprotein-derived cholesteryl ester. Eur J Biochem 2001; 268:5609-5616.
49. Frank PG, Pedraza A, Cohen DE, Lisanti MP. Adenovirus-mediated expression of caveolin-1 in mouse liver increases plasma high-density lipoprotein levels. Biochemistry 2001; 40:10892-10900.
50. Malerod L, Juvet K, Gjoen T, Berg T. The expression of scavenger receptor class B, type I (SR-BI) and caveolin-1 in parenchymal and nonparenchymal liver cells. Cell Tissue Res 2002; 307:173-180.
51. Briand O, Lestavel S, Pilon A, et al. SR-BI does not require raft/caveola localization for cholesteryl ester selective uptake in the human adrenal cell line NCI-H295R. Biochim Biophys Acta 2003; 1631:42-50.
52. Wang L, Connelly MA, Chen H, et al. Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines. J Lipid Res 2003; 44:807-815.
53. Levy EM. Ontogeny, immunolocalisation, distribution and function of SR-BI in the human intestine. J Cell Sci 2004; 117:327-337.
54. Reaven E, Leers-Sucheta S, Nomoto A, Azhar S. Expression of scavenger receptor class B type I (SR-BI) promotes microvillar channel formation and selective cholesteryl ester transport in a heterologous reconstituted system. Proc Natl Acad Sci U S A 2001; 98:1613-1618.
55. Williams DL, Wong JS, Hamilton RL. SR-BI is required for microvillar channel formation and the localization of HDL particles to the surface of adrenocortical cells in vivo. J Lipid Res 2002; 43:544-549.
56. Goldstein JL, Brown MS, Anderson RG, et al. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Ann Rev Cell Biol 1985; 1:1-39.
57. Sparrow CP, Pittman RC. Cholesterol esters selectively taken up from high-density lipoproteins are hydrolyzed extralysosomally. Biochim Biophys Acta Lipids Lipid Metab 1990; 1043:203-210.
58. DeLamatre JG, Carter RM, Hornick CA. Evidence that a neutral cholesteryl ester hydrolase is responsible for the extralysosomal hydrolysis of high-density lipoprotein cholesteryl ester in rat hepatoma cells (Fu5AH). J Cell Physiol 1993; 157:164-168.
59. Shimada A, Tamai T, Oida K, et al. Increase in neutral cholesteryl ester hydrolase activity produced by extralysosomal hydrolysis of high-density lipoprotein cholesteryl esters in rat hepatoma cells (H-35). Biochim Biophys Acta 1994; 1215:126-132.
60. Kraemer FB, Shen W-J, Harada K, et al. Hormone-sensitive liase is required for HDL cholesteryl ester-supported adrenal steroidogenesis. Mol Endocrinol 2004; 18:549-557.
61. Ji Y, Jian B, Wang N, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272:20982-20985.
62. de la Llera-Moya M, Rothblat GH, Connelly MA, et al. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Res 1999; 40:575-580.
63. Jian B, de la Llera-Moya M, Ji Y, et al. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 1998; 273:5599-5606.
64. Rothblat GH, de la Llera-Moya M, Atger V, et al. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999; 40:781-796.
65. Stangl H, Hyatt M, Hobbs HH. Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. J Biol Chem 1999; 274:32692-32698.
66. Ji Y, Wang N, Ramakrishnan R, et al. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 1999; 274:33398-33402.
67. Kozarsky KF, Donahee MH, Rigotti A, et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387:414-417.
68. Kellner-Weibel G, de la Llera-Moya M, Connelly MA, et al. Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry 2000; 39:221-229.
69. Connelly MA, de la Llera-Moya M, Monzo P, et al. Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI) are localized to the extracellular receptor domain. Biochemistry 2001; 40:5249-5259.
70. Connelly MA, de la Llera-Moya M, Peng Y, et al. Separation of lipid transport functions by mutations in the extracellular domain of scavenger receptor class B, type I (SR-BI). J Biol Chem 2003; 278:25773-25782. The A-VI mutant described in this report illustrates that the mechanism of SR-BI-mediated efflux of free cholesterol to HDL differs from the mechanism of efflux to phospholipid vesicle acceptors.
71. Rigotti A, Trigatti BL, Penman M, et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A 1997; 94:12610-12615.
72. Varban ML, Rinninger F, Wang N, et al. Targeted mutation reveals a central role of SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 1998; 95:4619-4624.
73. Wang N, Arai T, Ji Y, et al. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein apoB, low density lipoprotein apoB, and high density lipoprotein in transgenic mice. J Biol Chem 1998; 273:32920-32926.
74. Ueda Y, Royer L, Gong E, et al. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 1999; 274:7165-7171.
75. Rigotti A, Trigatti B, Babitt J, et al. Scavenger Receptor BI - a cell surface receptor for high density lipoprotein. Curr Opin Lipidol 1997; 8:181-188.
76. Swarnakar S, Temel RE, Connelly MA, et al. Scavenger receptor Class B, type I, mediates selective uptake of low density lipoprotein cholesteryl ester. J Biol Chem 1999; 274:29733-29739.
77. Ueda Y, Gong E, Royer L, et al. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 2000; 275:20368-20373.
78. Webb NR, De Beer MC, Yu J, et al. Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice. J Lipid Res 2002; 43:1421-1428.
79. Webb NR, De Beer MC, De Beer FC, van der Westhuyzen DR. ApoB-containing lipoproteins in apoE-deficient mice are not metabolized by the class B scavenger receptor BI. J Lipid Res 2004; 45:272-280.
80. Jeong T, Schissel SL, Tabas I, et al. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J Clin Invest 1998; 101:905-912.
81. Barter P, Kastelein J, Nunn A, et al. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 2003; 168:195-211.
82. Glomset JA. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res 1968; 9:155-167.
83. Uittenbogaard A, Shaul PW, Yuhanna IS, et al. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem 2000; 275:11278-11283.
84. Yuhanna IS, Zhu Y, Cox BE, et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 2001; 7:853-857.
85. Li XA, Titlow WB, Jackson BA, et al. High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J Biol Chem 2002; 277:11058-11063.
86. Mineo C, Yuhanna IS, Quon MJ, Shaul PW. HDL-induced eNOS activation is mediated by Akt and MAP kinases. J Biol Chem 2003; 278:9142-9149.
87. Gong M, Wilson M, Kelly T, et al. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 2003; 111:1579-1587. This report provides a very interesting view of how HDL associated estradiol stimulates eNOS activity and how SR-BI might be involved in the increased protection against atherosclerosis in premenopausal women.
88. (3). J Clin Invest 2004; 113:569-581. These authors show that eNOS activation by HDL particles may be in part due to the lysophospholipids they carry.
89. Shaul PWM. HDL action on the vascular wall: is the answer NO? J Clin Invest 2004; 113: 509-513. This commentary gives a quick review of HDL and SR-BI effects on nitric oxide production illustrating the key questions to be resolved.
90. Trigatti BC. Scavenger receptor class B type I in high-density lipoprotein metabolism, atherosclerosis and heart disease: lessons from gene-targeted mice. Biochem Soc Trans 2004; 32:116-120.
91. Trigatti B, Rayburn H, Vinals M, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A 1999; 96:9322-9327.
92. Braun A, Trigatti BL, Post MJ, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002; 90:270-276.
93. Braun A, Zhang S, Miettinen HE, et al. Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc Natl Acad Sci U S A 2003; 100:7283-7288.
94. Rinninger F, Wang N, Ramakrishnan R, et al. Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-I-dependent mechanism. Arterioscler Thromb Vasc Biol 1999; 19:1325-1332.
95. Huszar D, Varban ML, Rinninger F, et al. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice With attenuated expression of scavenger receptor BI. Arterioscler Thromb Vasc Biol 2000; 20:1068-1073.
96. Arai T, Wang N, Bezouevski M, et al. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999; 274:2366-2371.
97. Kozarsky KF, Donahee MH, Click JM, et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000; 20:721-727.
98. Van Eck M, Twisk J, Hoekstra M, et al. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J Biol Chem 2003; 278:23699-23705. This article is one of three that came out in 2003 emphasizing SR-BI macrophage expression and cholesterol efflux at the vessel wall as contributing to its negative effect on atherosclerotic plaque progression.
99. Zhang W, Yancey PG, Su YR, et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 2003; 108:2258-2263. This article is another of three that came out in 2003 emphasizing SR-BI macrophage expression and cholesterol efflux at the vessel wall as contributing to its negative effect on atherosclerotic plaque progression.
100. Covey SD, Krieger M, Wang W, et al. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2003; 23:1589-1594. This is the third article to be published in 2003 emphasizing SR-BI macrophage expression and cholesterol efflux at the vessel wall as contributing to its negative effect on atherosclerotic plaque progression.
101. Duncan KG, Bailey KR, Kane JP, Schwartz DM. Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochem Biophys Res Commun 2002; 292:1017-1022.
102. Ryeom SW, Silverstein RL, Scotto A, Sparrow JR. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J Biol Chem 1996; 271:20536-20539.
103. Husemann J, Loike JD, Anankov R, et al. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 2002; 40:195-205.
104. Kuniyasu A, Ohgami N, Hayashi S, et al. CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes. FEBS Lett 2003; 537:85-90.
105. Ohgami N, Nagai R, Miyazaki A, et al. Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products. J Biol Chem 2001; 276:13348-13355.
106. Miyazaki A, Nakayama H, Horiuchi S. Scavenger receptors that recognize advanced glycation end products. Trends Cardiovasc Med 2002; 12:258-262.
107. Kawasaki Y, Nakagawa A, Nagaosa K, et al. Phosphatidylserine binding of class B scavenger receptor type I, a phagocytosis receptor of testicular sertoli cells. J Biol Chem 2002; 277:27559-27566.
108. Puente NM, Daviet L, Ninio E, McGregor JL. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol 1996; 16:1033-1039.
109. Pearce SF, Roy P, Nicholson AC, et al. Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. J Biol Chem 1998; 273:34875-34881.
110. Marsche G, Zimmermann R, Horiuchi S, et al. Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J Biol Chem 2003; 278:47562-47570.
111. Marsche G, Hammer A, Oskolkova O, et al. Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J Biol Chem 2002; 277:32172-32179.
112. Gillotte-Taylor K, Boullier A, Witztum JL, et al. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J Lipid Res 2001; 42:1474-1482.
113. Vishnyakova TG, Bocharov AV, Baranova IN, et al. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J Biol Chem 2003; 278:22771-22780.